Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Astrazeneca Says US FDA Decision Date On Camizestrant Extended

    Picture of AstraZeneca logoAstraZeneca
    27/05/2026 07:30
    BRIEF-Astrazeneca Says US FDA Decision Date On Camizestrant Extended
    May 27 (Reuters) - AstraZeneca PLC AZN.L:
    • ASTRAZENECA PLC  - US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
    • ASTRAZENECA - FDA EXTENDS PDUFA DATE FOR CAMIZESTRANT NDA IN 1ST-LINE HR-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER
    • ASTRAZENECA - NDA BASED ON POSITIVE SERENA-6 PHASE III TRIAL RESULTS
    Source text: ID:nRSa7794Fa
    Further company coverage: AZN.L

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on AstraZeneca

    See all news